Cargando…

Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study

BACKGROUND: Hearing loss is an underestimated comorbid condition in type 2 diabetes. OBJECTIVES: Investigate hearing loss as a comorbidity associated with type 2 diabetes mellitus and evaluate the factors associated with hearing loss. DESIGN: Cross-sectional. SETTING: Tertiary care center, diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Rubeaan, Khalid, AlMomani, Murad, AlGethami, Aisha Khalaf, Darandari, Jamal, Alsalhi, Abdulaziz, AlNaqeeb, Dehkra, Almogbel, Ebtehal, Almasaari, Fatima H., Youssef, Amira M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176373/
https://www.ncbi.nlm.nih.gov/pubmed/34085541
http://dx.doi.org/10.5144/0256-4947.2021.171
_version_ 1783703248968876032
author Al-Rubeaan, Khalid
AlMomani, Murad
AlGethami, Aisha Khalaf
Darandari, Jamal
Alsalhi, Abdulaziz
AlNaqeeb, Dehkra
Almogbel, Ebtehal
Almasaari, Fatima H.
Youssef, Amira M.
author_facet Al-Rubeaan, Khalid
AlMomani, Murad
AlGethami, Aisha Khalaf
Darandari, Jamal
Alsalhi, Abdulaziz
AlNaqeeb, Dehkra
Almogbel, Ebtehal
Almasaari, Fatima H.
Youssef, Amira M.
author_sort Al-Rubeaan, Khalid
collection PubMed
description BACKGROUND: Hearing loss is an underestimated comorbid condition in type 2 diabetes. OBJECTIVES: Investigate hearing loss as a comorbidity associated with type 2 diabetes mellitus and evaluate the factors associated with hearing loss. DESIGN: Cross-sectional. SETTING: Tertiary care center, diabetes clinic. PATIENTS AND METHODS: Patients with type 2 diabetes, aged 30 to 60 years, were randomly selected to participate. All patients underwent clinical ear examinations and were referred for full audiological evaluation. Otoacoustic emission was used to assess inner function, tympanometry to assess middle-ear function, and pure tone air/bone audiometry to assess hearing sensitivity. Risk factors for hearing loss were assessed by multivariate logistic regression. MAIN OUTCOME MEASURE: Frequency, severity and risk factors for hearing loss. SAMPLE SIZE: 157 RESULTS: Of the 157 patients, 77 had hearing loss in both ears (49.0%), 13 in the right ear only (8.3%), 14 in the left ear only (8.9%), and 53 (33.8%) had normal hearing. In the 181 ears with sensorineural hearing loss, 90 had mild loss (49.7%), 69 moderate loss (38.2%), 16 severe loss (8.8%) and 6 had profound loss (3.3%). Disabling hearing loss was observed in 46 (29%) patients. A higher frequency of hearing loss was present in patients with glycated hemoglobin levels ≥8%. In the multivariate logistic regression analysis, the most important factors associated with hearing loss were longer diabetes duration, poor glycemic control and the presence of hypertension. CONCLUSIONS: Hearing loss is an underestimated comorbid condition in type 2 diabetes that warrants frequent hearing assessments and management. Strict glycemic and hypertension control is essential for the minimization of the effects of diabetes on hearing sensitivity. LIMITATIONS: Small sample size, limited age window (30-60 years), which was chosen to eliminate the natural aging effect on hearing. Cross-sectional nature was not ideal for the assessment of causality. CONFLICT OF INTEREST: None.
format Online
Article
Text
id pubmed-8176373
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher King Faisal Specialist Hospital and Research Centre
record_format MEDLINE/PubMed
spelling pubmed-81763732021-06-07 Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study Al-Rubeaan, Khalid AlMomani, Murad AlGethami, Aisha Khalaf Darandari, Jamal Alsalhi, Abdulaziz AlNaqeeb, Dehkra Almogbel, Ebtehal Almasaari, Fatima H. Youssef, Amira M. Ann Saudi Med Original Article BACKGROUND: Hearing loss is an underestimated comorbid condition in type 2 diabetes. OBJECTIVES: Investigate hearing loss as a comorbidity associated with type 2 diabetes mellitus and evaluate the factors associated with hearing loss. DESIGN: Cross-sectional. SETTING: Tertiary care center, diabetes clinic. PATIENTS AND METHODS: Patients with type 2 diabetes, aged 30 to 60 years, were randomly selected to participate. All patients underwent clinical ear examinations and were referred for full audiological evaluation. Otoacoustic emission was used to assess inner function, tympanometry to assess middle-ear function, and pure tone air/bone audiometry to assess hearing sensitivity. Risk factors for hearing loss were assessed by multivariate logistic regression. MAIN OUTCOME MEASURE: Frequency, severity and risk factors for hearing loss. SAMPLE SIZE: 157 RESULTS: Of the 157 patients, 77 had hearing loss in both ears (49.0%), 13 in the right ear only (8.3%), 14 in the left ear only (8.9%), and 53 (33.8%) had normal hearing. In the 181 ears with sensorineural hearing loss, 90 had mild loss (49.7%), 69 moderate loss (38.2%), 16 severe loss (8.8%) and 6 had profound loss (3.3%). Disabling hearing loss was observed in 46 (29%) patients. A higher frequency of hearing loss was present in patients with glycated hemoglobin levels ≥8%. In the multivariate logistic regression analysis, the most important factors associated with hearing loss were longer diabetes duration, poor glycemic control and the presence of hypertension. CONCLUSIONS: Hearing loss is an underestimated comorbid condition in type 2 diabetes that warrants frequent hearing assessments and management. Strict glycemic and hypertension control is essential for the minimization of the effects of diabetes on hearing sensitivity. LIMITATIONS: Small sample size, limited age window (30-60 years), which was chosen to eliminate the natural aging effect on hearing. Cross-sectional nature was not ideal for the assessment of causality. CONFLICT OF INTEREST: None. King Faisal Specialist Hospital and Research Centre 2021-06 2021-06-01 /pmc/articles/PMC8176373/ /pubmed/34085541 http://dx.doi.org/10.5144/0256-4947.2021.171 Text en Copyright © 2021, Annals of Saudi Medicine, Saudi Arabia https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). The details of which can be accessed at http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Article
Al-Rubeaan, Khalid
AlMomani, Murad
AlGethami, Aisha Khalaf
Darandari, Jamal
Alsalhi, Abdulaziz
AlNaqeeb, Dehkra
Almogbel, Ebtehal
Almasaari, Fatima H.
Youssef, Amira M.
Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study
title Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study
title_full Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study
title_fullStr Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study
title_full_unstemmed Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study
title_short Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study
title_sort hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176373/
https://www.ncbi.nlm.nih.gov/pubmed/34085541
http://dx.doi.org/10.5144/0256-4947.2021.171
work_keys_str_mv AT alrubeaankhalid hearinglossamongpatientswithtype2diabetesmellitusacrosssectionalstudy
AT almomanimurad hearinglossamongpatientswithtype2diabetesmellitusacrosssectionalstudy
AT algethamiaishakhalaf hearinglossamongpatientswithtype2diabetesmellitusacrosssectionalstudy
AT darandarijamal hearinglossamongpatientswithtype2diabetesmellitusacrosssectionalstudy
AT alsalhiabdulaziz hearinglossamongpatientswithtype2diabetesmellitusacrosssectionalstudy
AT alnaqeebdehkra hearinglossamongpatientswithtype2diabetesmellitusacrosssectionalstudy
AT almogbelebtehal hearinglossamongpatientswithtype2diabetesmellitusacrosssectionalstudy
AT almasaarifatimah hearinglossamongpatientswithtype2diabetesmellitusacrosssectionalstudy
AT youssefamiram hearinglossamongpatientswithtype2diabetesmellitusacrosssectionalstudy